Oral phosphatidylcholine preserves the gastrointestinal mucosal barrier during LPS-induced inflammation

Shock

Volumn 30, Issue 6, 2008, Pages 729-733

  Dial, Elizabeth J ^a,c   Zayat, Mayssa ^b   Lopez Storey, Michelle ^a   Tran, Duy ^a   Lichtenberger, Lenard ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF TEXAS   (United States)

Author keywords

Intestine; LPS; Phosphatidylcholine; Stomach

Indexed keywords

BILE ACID; HEMOGLOBIN; LIPOPOLYSACCHARIDE; PHOSPHATIDYLCHOLINE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIGESTIVE SYSTEM INFLAMMATION; DIGESTIVE SYSTEM INJURY; DRUG DISTRIBUTION; DRUG EFFECT; DRUG METABOLISM; DRUG TISSUE LEVEL; GASTROINTESTINAL MUCOSA; GASTROINTESTINAL TRACT; ILEUM; INTESTINE MUCOSA PERMEABILITY; ISOTOPE LABELING; MALE; NONHUMAN; PROTEIN BLOOD LEVEL; RAT; SMALL INTESTINE; STOMACH; STOMACH HEMORRHAGE; STOMACH JUICE; STOMACH PH;

ADMINISTRATION, ORAL; ANIMALS; GASTRIC MUCOSA; HYDROGEN-ION CONCENTRATION; INFLAMMATION; INTESTINAL MUCOSA; LIPOPOLYSACCHARIDES; MALE; PHOSPHATIDYLCHOLINES; RATS; RATS, SPRAGUE-DAWLEY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 58149267569     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/SHK.0b013e318173e8d4     Document Type: Article

References (29)

1. Lichtenberger LM: Gastroduodenal mucosal defense. Curr Opin Gastroenterol 15:463-472, 1999.
2. Kaunitz JD: Barrier function of gastric mucus. Keio J Med 48:63-68, 1999.
3. Allen A, Flemstrom G: Gastroduodenal mucus bicarbonate barrier: protection against acid and pepsin. Am J Physiol Cell Physiol 288:C1-C19, 2005.
4. Hills BA, Butler BD, Lichtenberger LM: Gastric mucosal barrier: hydrophobic lining to the lumen of the stomach. Am J Physiol Gastrointest Liver Physiol 244:G561-G568, 1983.
5. Goggin PM, Marrero JM, Spychal RT, Jackson PA, Corbishley CM, Northfield TC: Surface hydrophobicity of gastric mucosa in Helicobacter pylori infection: effect of clearance and eradication. Gastroenterology 103:1486-1490, 1992.
6. Lugea A, Antolin M, Mourelle M, Guamer F, Malagelada JR: Deranged hydrophobic barrier of the rat gastroduodenal mucosa after parenteral nonsteroidal anti-inflammatory drugs. Gastroenterology 112:1931-1939, 1997.
7. Lichtenberger LM, Dial EJ, Ottlecz A, Romero JJ, Lechago J, Fox JG: Attenuation of hydrophobic phospholipid barrier is an early event in Helicobacter felis-induced gastritis in mice. Dig Dis Sci 44:108-115, 1999.
8. Lichtenberger LM, Zhou Y, Dial FJ, Raphael RM: NSAID injury to the gastrointestinal tract: evidence that NSAIDs interact with phospholipids to weaken the hydrophobic surface barrier and induce the formation of unstable pores in membranes. J Pharm Pharmacol 58:1421-1428, 2006.
9. Qin X, Caputo X, Xu D-Z, Deitch EA: Hydrophobicity of mucosal surface and its relationship to gut barrier functioa Shock 29:372-376, 2008.
10. Dial EJ, Romero JJ, Villa X, Mercer DW, Lichtenberger LM: Lipopolysaccharide-induced gastrointestinal injury in rats: role of surface hydrophobicity and bile salts. Shock 17:77-80, 2002.
11. Zayat M, Lichtenberger LM, Dial EJ: Pathophysiology of LPS-induced gastrointestinal injury in the rat: role of secretory phospholipase A2. Shock 30:206-211,2008.
12. Karlqvist P-A, Franzen L, Sjodahl R, Tagesson C: A study of the permeability of rat stomach to larger molecules. Influence of lysophosphatidylcholine. Acta Chir Scand 152:279-284, 1986.
13. Lichtenberger L, Ulloa C, Romero J, Vanous A, Illich P, Dial E: Nonsteroidal anti-inflammatory drug and phospholipid prodrugs: combination therapy with antisecretory agents in rats. Gastroenterology 111:990-995, 1996.
14. Folch J, Lees M, Sloane Stanley GH: A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 226:497-509, 1957.
15. Lichtenberger LM, Graziani LA, Dial EJ, Butler BD, Hills BA: Role of surface-active phospholipids in gastric cytoprotection. Science 219:1327-1329, 1983.
16. Orchard R, Reynolds K, Fox B, Andrews R, Parkins A, Johnson AG: Effect of lysolecithin on gastric mucosal structure and potential difference. Gut 18: 457-461, 1977.
17. Tagesson C, Franzen L, Dahl G, Westrom B: Lysophosphatidylcholine increases rat ileal permeability to macromolecules. Gut 26:369-377, 1985.
18. Tannaes T, Bukholm IK, Bukholm G: High relative content of lysophospholipids of Helicobacter pylori mediates increased risk for ulcer disease. FEMS Immunol Med Microbiol 44:17-23, 2005.
19. Hermann GE, Tovar CA, Rogers RC: LPS-induced suppression of gastric motility relieved by TNFR:Fc construct in dorsal vagal complex. Am J Physiol Gastrointest Liver Physiol 283:G634-639, 2002.
20. West SD, Suliburk JW, Smith GS, Mercer DW: Effects of lipopolysaccharide on gastric stasis: role of cyclo-oxygenase. Dig Dis Sci 51:754-765, 2006.
21. Szelenyi I, Engler H: Cytoprotective role of gastric surfactant in the ethanolproduced mucosal injury of the rat. Pharmacology 33:199-205, 1986.
22. Swarm RA, Ashley SW, Soybel DI, Ordway FS, Cheung LY: Protective effect of exogenous phospholipid on aspirin-induced gastric mucosal injury. Am J Surg 153:48-53, 1987.
23. Dial EJ, Lichtenberger LM:Brole for milk phospholipids in protection against gastric acid. Studies in adult and suckling rats. Gastroenterology 87:379-385, 1984.
24. Romero JJ, Lichtenberger LM: Sterol-dependence of gastric protective activity of unsaturated phospholipids. Dig Dis Sci 35:1231-1238, 1990.
25. Lichtenberger LM, Romero JJ, Kao Y-CJ, Dial EJ: Gastric protective activity of mixtures of saturated polar and neutral lipids in rats. Gastroenterology 99:311-326, 1990.
26. Stremmel W, Merle U, Zahn A, Autschbach F, Hinz U, Ehehalt R: Retarded release phosphatidylcholine benefits patients with chronic active ulcerative colitis. Gut 54:966-971, 2005.
27. Stremmel W, Ehehalt R, Autschbach R, Karner M: Phosphatidylcholine for steroid-refractory chronic ulcerative colitis. A randomized trial. Ann Intern Med 147:603-610, 2007.
28. Treede I, Braun A, Sparla R, Kuhnel M, Giese T, Turner JR, Anes E, Kulaksiz H, Fullekrug J, Stremmel W, et al.: Anti-inflammatory effects of phosphatidylcholine. J Biol Chem 282:27155-27164, 2007.
29. Gordon B, Parker TS, Levine DM, Feuerbach F, Saal SD, Sloan B-J, Chu C, Stenzel KH, Parrillo JE, Rubin AL: Neutralization of endotoxin by a phospholipid emulsion in healthy volunteers. J Infect Dis 191:1515-1522, 2005.